| Sarah Schaaf, MSED, CCC-SLP | |
|
4215 Avenue I, Scottsbluff, NE 69361-4902 | |
| (308) 635-3696 | |
| Not Available |
| Full Name | Sarah Schaaf |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4215 Avenue I, Scottsbluff, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770937898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12152907 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Schaaf, MSED, CCC-SLP 4215 Avenue I, Scottsbluff, NE 69361-4902 Ph: (308) 635-3696 | Sarah Schaaf, MSED, CCC-SLP 4215 Avenue I, Scottsbluff, NE 69361-4902 Ph: (308) 635-3696 |
News Archive
A lack of national data and indicators in the UK makes it difficult for rheumatologists to demonstrate effective care for patients with inflammatory arthritis. This also leaves patients without the information they need to take control of their care.
More resilient people tend to have a higher pain tolerance. Resilience, a person's ability to overcome adverse circumstances, is the main quality associated with pain tolerance among patients and their adjustment to chronic pain.
Roche`s RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). The Roche kit detects RNA from the 2009 H1N1 influenza A virus and allows rapid and accurate identification of patients infected with this virus.
The Scripps Research Institute has been awarded a $2.35 million grant from the National Institutes of Health to study a new way of treating obesity as part of a national consortium with the Dana-Farber Cancer Institute.
Huntsman Cancer Institute researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard treatments for chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic lymphoma.
› Verified 3 days ago
Rachel Leigh Pohlmann, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4215 Avenue I, Scottsbluff, NE 69361 Phone: 308-635-3696 | |
Kristen Nelson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-630-1355 | |
Jocelyn Mellen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3911 Avenue B, Suite G 200, Scottsbluff, NE 69361 Phone: 308-630-1355 | |
Polli Kinsey, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1306 9th Ave, Scottsbluff, NE 69361 Phone: 308-635-6259 | |
Kay L. Wallace, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 W 36th St, Scottsbluff, NE 69361 Phone: 308-635-2019 | |
Mrs. Laura Lee, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4215 Avenue I, Scottsbluff, NE 69361 Phone: 308-635-3696 | |
Jean M Wegelin, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 Avenue L, Scottsbluff, NE 69361 Phone: 308-631-5088 |